company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4201264000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,28781000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4230045000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,768771000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,768771000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3461274000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,705741000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,591026000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1296767000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2164507000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,63181000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,109823000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,46642000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2211149000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,635355000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1575794000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1575794000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9108000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1584902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,929133000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,964356000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.64
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,926800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 16:28:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5302976000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,32774000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5335750000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1127246000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1127246000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4208504000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,797344000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,732619000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1529963000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2678541000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65244000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59401000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5843000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2672698000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,702363000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1970335000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1970335000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8564000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1978899000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,920693000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,958825000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,920400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 16:40:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1363663000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,7605000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1371268000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,300183000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,300183000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1071085000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,189189000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,188062000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,377251000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,693834000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16382000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3637000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12745000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,681089000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,187396000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,493693000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,493693000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2160000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,495853000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,920807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,960585000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,918200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q3,2008-07-01,2008-09-30,2009-11-05 16:44:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1267824000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,10301000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1278125000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,265684000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,265684000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1012441000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,219533000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187393000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,406926000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,605515000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16428000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14026000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2402000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,603113000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,170490000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,432623000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,432623000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2160000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,434783000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,922796000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,965663000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,925100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2008.0,Q2,2008-04-01,2008-06-30,2009-08-05 16:44:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2027146000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5233000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2032379000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,473399000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,473399000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1558980000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,253897000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,239645000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,493542000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1065438000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17290000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11299000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5991000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1059447000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,260054000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,799393000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,799393000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2819000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,802212000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,904604000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,934109000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,905800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6961129000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,50254000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7011383000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1595558000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1595558000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5415825000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,946686000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,939918000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1886604000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3529221000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69662000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42397000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27265000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3501956000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,876364000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2625592000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2625592000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10163000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2635755000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,904604000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.91
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,934109000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.82
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,905800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,FY,2009-01-01,2009-12-31,2012-02-23 16:18:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.91
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4933983000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,45021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4979004000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1122159000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1122159000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3856845000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,692789000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,700273000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1393062000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2463783000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52372000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31098000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21274000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2442509000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,616310000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1826199000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1826199000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7344000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1833543000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,903319000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,932424000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,897400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3YTD,2009-01-01,2009-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.09
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1791088000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,10301000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1801389000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,409700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,409700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1391689000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,227427000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,269856000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,497283000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,894406000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17217000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14017000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,891206000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,220728000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,670478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,670478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2555000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,673033000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,903319000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,932424000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,897400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 17:02:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3142895000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,34720000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3177615000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,712459000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,712459000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2465156000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,465362000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,430417000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,895779000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1569377000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,35155000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,17081000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18074000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1551303000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,395582000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1155721000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1155721000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4789000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1160510000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,905611000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.28
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,934478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,907000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.28
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2YTD,2009-01-01,2009-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1642273000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4882000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1647155000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,383045000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,383045000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1264110000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,261411000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,241638000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,503049000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,761061000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18484000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12923000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5561000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,755500000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,186355000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,569145000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,569145000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2253000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,571398000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,905611000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,934478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,907000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 06:20:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1500622000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,29838000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1530460000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,329414000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,329414000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1201046000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,203951000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,188779000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,392730000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,808316000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16671000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4158000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12513000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,795803000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,209227000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,586576000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,586576000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2536000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,589112000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,909780000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,942479000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,906300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2009.0,Q1,2009-01-01,2009-03-31,2010-05-10 16:16:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1995379000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3308000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1998687000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,496337000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,496337000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1502350000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,280209000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,392760000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,672969000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,829381000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40622000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10764000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29858000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,799523000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173158000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,626365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,626365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3054000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,629419000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1712120000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1746792000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1716700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7935891000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13529000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7949420000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1869876000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1869876000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6079544000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1044392000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1072930000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2117322000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3962222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,108961000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60287000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48674000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3913548000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1023799000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2889749000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2889749000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11508000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2901257000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1712120000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1746792000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.66
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1716700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:36:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5940512000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,10221000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5950733000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1373539000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1373539000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4577194000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,764183000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,680170000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1444353000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3132841000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,68339000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49523000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18816000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3114025000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,850641000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2263384000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2263384000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8454000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2271838000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,833006000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.73
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,847228000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.73
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,829300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.73
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3YTD,2010-01-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7967658000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,15454000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7983112000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1846938000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1846938000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6136174000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1018080000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,919815000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1937895000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4198279000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85629000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60822000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4173472000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1110695000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3062777000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3062777000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11273000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3074050000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,833006000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,847228000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,829300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.09
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1934917000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2739000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1937656000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,477584000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,477584000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1460072000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,250559000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,230440000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,480999000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,979073000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33620000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15593000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18027000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,961046000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,258883000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,702163000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,702163000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2713000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,704876000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,833006000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,847228000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,829300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:50:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4005595000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,7482000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4013077000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,895955000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,895955000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3117122000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,513624000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,449730000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,963354000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2153768000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,34719000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33930000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-789000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2152979000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,591758000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1561221000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1561221000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5741000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1566962000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,881802000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,898753000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,879100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2YTD,2010-01-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7823829000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,23016000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7846845000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1779054000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1779054000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6067791000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,994948000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,959231000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1954179000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4113612000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69226000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59246000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9980000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4103632000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1072540000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3031092000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3031092000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11115000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3042207000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,881802000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,898753000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,879100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1923851000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3373000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1927224000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,455525000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,455525000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1471699000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,248006000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,231066000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,479072000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,992627000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17764000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18285000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,521000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,993148000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,284021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,709127000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,709127000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2934000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,712061000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,881802000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,898753000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,879100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:48:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7542251000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24525000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7566776000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1706574000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1706574000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5860202000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1008353000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,969803000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1978156000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3882046000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69946000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53884000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16062000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3865984000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,974874000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2891110000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2891110000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10434000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2901544000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,901606000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,928368000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,899900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1TTM,2009-04-01,2010-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2081744000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4109000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2085853000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,440430000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,440430000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1645423000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,265618000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,218664000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,484282000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1161141000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16955000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15645000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1310000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1159831000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,307737000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,852094000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,852094000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,854901000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,901606000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,928368000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,899900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:35:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2197546000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2832000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2200378000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,584447000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,584447000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1615931000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,346219000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,402236000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,748455000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,867476000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,74998000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48633000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,818843000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,157084000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,661759000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,661759000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3386000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,665145000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1549806000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1580236000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1549000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8371186000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,14199000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8385385000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2124410000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2124410000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6260975000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1241983000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1229151000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2471134000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3789841000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,205418000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,66581000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-138837000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3651004000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,861945000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2789059000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2789059000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14578000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2803637000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1549806000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.81
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1580236000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.77
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1549000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 16:10:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.81
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6173640000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,11367000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6185007000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1539963000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1539963000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4645044000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,895764000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,826915000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1722679000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2922365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,130420000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,40216000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-90204000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2832161000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,704861000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2127300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2127300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11192000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2138492000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,767033000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.79
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,781312000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.79
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,764000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.79
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8169019000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,14675000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8183694000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2036300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2036300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6147394000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1175973000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1219675000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2395648000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3751746000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,171042000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50980000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-120062000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3631684000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,878019000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2753665000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2753665000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14246000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2767911000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,767033000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,781312000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,764000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2117488000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4172000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2121660000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,531989000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,531989000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1589671000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,295927000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,290066000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,585993000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1003678000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43097000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14406000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28691000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,974987000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,237449000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,737538000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,737538000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3586000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,741124000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,767033000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.97
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,781312000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,764000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:06:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.97
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4056152000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,7195000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4063347000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1007974000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1007974000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3055373000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,599837000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,536849000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1136686000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1918687000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,87323000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25810000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61513000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1857174000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,467412000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1389762000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1389762000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7606000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1397368000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,784807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,785500000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2YTD,2011-01-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7986448000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13242000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7999690000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1981895000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1981895000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6017795000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1130605000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1160049000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2290654000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3727141000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,161565000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,52167000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-109398000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3617743000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,899453000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2718290000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2718290000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13373000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2731663000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,784807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.48
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.48
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,785500000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.48
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2133909000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3344000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2137253000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,533863000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,533863000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1603390000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,304269000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,282403000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,586672000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1016718000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46107000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11978000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34129000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,982589000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,240130000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,742459000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,742459000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3768000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,746227000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,784807000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,785500000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q2,2011-04-01,2011-06-30,2012-08-01 15:58:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7776390000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13271000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7789661000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1903557000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1903557000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5886104000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1074342000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1108712000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2183054000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3703050000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,133222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,58474000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-74748000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3628302000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,943344000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2684958000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2684958000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12539000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2697497000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,796115000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,811857000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,794100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.1
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1922243000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3851000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1926094000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,474111000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,474111000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1451983000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,295568000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,254446000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,550014000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,901969000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41216000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13832000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27384000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,874585000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,227282000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,647303000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,647303000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3838000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,651141000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,796115000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,811857000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,794100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:26:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2598314000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-10546000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2587768000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,675455000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,675455000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1912313000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,365791000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,439714000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,805505000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1106808000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85990000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1665000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84325000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1022483000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,263123000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,759360000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,759360000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3615000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,762975000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1515000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1583000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1515800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9702000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9702000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2471000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2471000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7231000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1461000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1760000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3221000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4010000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,361000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-398000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3612000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1038000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2574000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2574000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-18000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2592000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1515000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1583000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.64
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1515800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 16:05:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7103686000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,10546000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7114232000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1795545000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1795545000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5318687000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1095209000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1320286000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2415495000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2903192000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,275010000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38665000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-313675000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2589517000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,774877000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1814640000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1814640000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14385000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1829025000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514770000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1584608000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1501100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.02
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9301232000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13378000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9314610000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2379992000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2379992000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6934618000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1441428000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1722522000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3163950000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3770668000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,350008000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-362308000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3408360000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,931961000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2476399000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2476399000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17771000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2494170000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514770000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1584608000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1501100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2421893000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4704000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2426597000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,597269000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,597269000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1829328000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,319583000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,465831000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,785414000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1043914000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,89322000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3505000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-92827000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,951087000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,280052000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,671035000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,671035000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4470000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,675505000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514770000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1584608000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1501100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q3,2012-07-01,2012-09-30,2013-10-31 16:40:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4681793000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5842000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4687635000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1198276000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1198276000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3489359000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,775626000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,854455000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1630081000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1859278000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,185688000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35160000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-220848000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1638430000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,494825000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1143605000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1143605000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9915000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1153520000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1513902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1561012000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8996827000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,12846000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9009673000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2314712000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2314712000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6694961000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1417772000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1546757000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2964529000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3730432000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,303783000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5611000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-298172000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3432260000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,889358000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2542902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2542902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16887000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2559789000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1513902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1561012000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2402346000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2840000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2405186000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,617345000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,617345000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1787841000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,332505000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,396244000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,728749000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1059092000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88418000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1075000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89493000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,969599000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,263525000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,706074000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,706074000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5490000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,711564000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1513902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1561012000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8728390000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13350000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8741740000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2231230000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2231230000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6510510000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1389536000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1432916000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2822452000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3688058000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261472000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18664000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-242808000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3445250000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,865963000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2579287000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2579287000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15165000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2594452000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1512572000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1554776000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1524000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2279447000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3002000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2282449000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,580931000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,580931000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1701518000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,443121000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,458211000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,901332000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,800186000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,97270000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34085000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-131355000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,668831000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,231300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,437531000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,437531000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4425000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,441956000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1512572000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1554776000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1524000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 17:15:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11202000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11202000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2859000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2859000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8343000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1699000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2120000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3819000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4524000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-316000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4208000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1151000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3057000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3057000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-18000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3075000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1529000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1695000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.81
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1529900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,FY,2013-01-01,2013-12-31,2016-02-24 17:01:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3120138000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3120138000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,858021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,858021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2262117000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,512853000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,552222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1065075000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1197042000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,73256000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-84478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1112564000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,326108000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,786456000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,786456000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5147000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,791603000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1529000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1695000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1529900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8081862000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8081862000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2000979000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2000979000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6080883000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1186147000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1567778000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2753925000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3326958000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,233744000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-231522000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3095436000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,824892000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2270544000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2270544000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12853000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2283397000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1532105000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1691898000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.49
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1546300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10680176000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-10546000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10669630000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2676434000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2676434000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7993196000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1551938000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2007492000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3559430000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4433766000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,319734000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3887000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-315847000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4117919000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1088015000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3029904000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3029904000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16468000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3046372000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1532105000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.99
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1691898000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1546300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.99
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.12
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2782833000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2782833000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,681868000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,681868000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2100965000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,406860000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,546244000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,953104000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1147861000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,73949000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5777000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68172000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1079689000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,294473000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,785216000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,785216000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3390000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,788606000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1532105000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1691898000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1546300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 16:28:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5299029000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5299029000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1319111000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1319111000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3979918000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,779287000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1021534000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1800821000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2179097000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,159795000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3555000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-163350000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2015747000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,530419000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1485328000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1485328000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9463000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1494791000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1526945000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1694577000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10319236000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-5842000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10313394000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2591835000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2591835000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7721559000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1464661000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1927079000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3391740000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4329819000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,335107000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5395000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-340502000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3989317000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1073594000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2915723000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2915723000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17548000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2933271000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1526945000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1694577000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.12
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2767394000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2767394000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,684663000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,684663000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2082731000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,404991000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,523902000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,928893000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1153838000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,78008000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-231000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-78239000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1075599000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,307981000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,767618000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,767618000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4987000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,772605000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1526945000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1694577000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1514900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 17:19:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9954188000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-3002000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9951186000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2524517000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2524517000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7426669000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1392175000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1799421000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3191596000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4235073000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,345517000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6239000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-351756000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3883317000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1029138000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2854179000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2854179000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-18051000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2872230000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1521372000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1665060000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.89
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1536600000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.14
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2531635000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2531635000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,634448000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,634448000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1897187000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,374296000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,497632000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,871928000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1025259000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,81787000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3324000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85111000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,940148000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,222438000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,717710000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,717710000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4476000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,722186000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1521372000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1665060000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1536600000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 17:19:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24474000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,416000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24890000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3788000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3788000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21102000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2983000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2854000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5837000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15265000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,412000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-409000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14856000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2797000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12059000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12059000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-42000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12101000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1522000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,7.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1647000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.35
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1522100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.95
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,FY,2014-01-01,2014-12-31,2017-02-27 16:23:29+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6898000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,416000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7314000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1063000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1063000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6251000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,876000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1045000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1921000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4330000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,130000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-100000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4230000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,768000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3462000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3462000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3487000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1522000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1647000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1522100000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.06
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6042000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6042000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,987000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,987000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5055000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,945000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,630000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1575000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3480000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,104000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-109000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,647000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2724000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2724000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2731000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1637000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.67
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 16:02:41+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17576000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17576000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2725000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2725000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14851000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2107000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1809000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3916000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10935000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,282000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-309000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10626000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2029000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8597000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8597000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8614000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1637000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.04
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20696138000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20696138000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3583021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3583021000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17113117000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2619853000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2361222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4981075000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12132042000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,355256000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38222000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-393478000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11738564000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2355108000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9383456000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9383456000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-22147000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9405603000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1637000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1517200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11534000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11534000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1738000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1738000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9796000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1162000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1179000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7455000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,178000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7255000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1382000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5873000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5873000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5883000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1533000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.84
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.84
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1529700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.84
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17436971000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17436971000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3277889000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3277889000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14159082000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2081713000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2277466000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4359179000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9799903000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,325205000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27445000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-352650000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9447253000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2002581000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7444672000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7444672000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-18537000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7463209000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1533000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.87
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.87
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1529700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.87
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6535000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6535000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,925000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,925000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5610000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,614000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,584000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1198000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4412000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,102000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4306000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,656000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3650000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3650000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3656000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1533000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1664000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1529700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:19:50+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13669365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13669365000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3037552000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3037552000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10631813000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1872704000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2217368000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4090072000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6541741000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,301213000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23676000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-324889000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6216852000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1654562000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4562290000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4562290000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17524000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4579814000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1537000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1680000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1535900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.06
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4999000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4999000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,813000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,813000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4186000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,548000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,595000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1143000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3043000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,76000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-94000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2949000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,726000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2223000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2223000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2227000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1537000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1680000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1535900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:30:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.45
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32151000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32639000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4006000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4006000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28633000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3426000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3014000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6440000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22193000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,688000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,154000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-534000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21659000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3553000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18108000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1464000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1521000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.91
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1463900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:57:33+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.29
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8018000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8506000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1062000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1062000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7444000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1066000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,757000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1823000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5621000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,230000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-184000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5437000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,752000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4683000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1464000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.27
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1521000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.17
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1463900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.27
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8295000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8295000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1064000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1064000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7231000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,903000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,743000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1646000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5585000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,165000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,52000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-113000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5472000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,880000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4592000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4592000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4600000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1463000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.14
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1503000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.06
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.14
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:45:11+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24133000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24133000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2944000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2944000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21189000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2360000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2257000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4617000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16572000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,458000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,108000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-350000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16222000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2801000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13421000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13421000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13425000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1463000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1503000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31031000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,416000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31447000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4007000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4007000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27440000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3236000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3302000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6538000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20902000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,588000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,138000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-450000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20452000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3569000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16883000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16883000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-29000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16912000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1463000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.56
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1503000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.56
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.56
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.7
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8244000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8244000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,998000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,998000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7246000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,812000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,818000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1630000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5616000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,140000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-105000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5511000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1014000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4497000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4497000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4492000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1472000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1540000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1472800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:12:17+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15838000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15838000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1880000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1880000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13958000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1457000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1514000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2971000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10987000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,293000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-237000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10750000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1921000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8829000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8829000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8825000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1472000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1540000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1472800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28778000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,416000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29194000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3930000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3930000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25264000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3278000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3189000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6467000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18797000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,527000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-446000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18351000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3336000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15015000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15015000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15043000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1472000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1540000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1472800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7594000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7594000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,882000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,882000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6712000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,645000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,696000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,153000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-132000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5239000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,907000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4332000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4332000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4333000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.91
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1569000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1489000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.91
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:15:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27069000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,416000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27485000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3857000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3857000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23628000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3080000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2955000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6035000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17593000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,489000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-447000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17146000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2978000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14168000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14168000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-39000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14207000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.55
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1569000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.55
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1489000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.55
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30390000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30390000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4261000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4261000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26129000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3398000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5098000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8496000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17633000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,964000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,428000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-536000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17097000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3609000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13501000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,10.08
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1358000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.94
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1339400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.08
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 20:02:58+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.84
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7540000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-220000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1075000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1075000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6245000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,992000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1208000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2200000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4045000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,265000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,140000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-125000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3920000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,821000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3099000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3099000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3108000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.36
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1358000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.34
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1339400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.36
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7405000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,95000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7500000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1129000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1129000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,831000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1141000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1972000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4399000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,242000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,119000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-123000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4276000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,951000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3325000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3325000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3330000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1322000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.49
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1321400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 18:07:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22850000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,220000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23070000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3186000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3186000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19884000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2406000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3890000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6296000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13588000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,699000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,288000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13177000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2788000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10389000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10389000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10393000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1322000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.6
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1321400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.37
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30868000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,708000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31576000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4248000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4248000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27328000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3472000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4647000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8119000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19209000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,929000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,334000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-595000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18614000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3540000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15074000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15074000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15076000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1322000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.99
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.77
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1321400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.99
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.8
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7651000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,125000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7776000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,864000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,864000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6912000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,890000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1484000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2374000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4538000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,227000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-139000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4399000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,902000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3497000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3497000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3497000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1335000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.62
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1355000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.58
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1334700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.62
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 16:31:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15445000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,125000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2057000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2057000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13513000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1575000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2749000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4324000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9189000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,457000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,169000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-288000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8901000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1837000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7064000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7064000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7063000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1335000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1355000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1334700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.9
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31758000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,613000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4183000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4183000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28188000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3544000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4249000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7793000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20395000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,852000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-585000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19810000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3469000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16346000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1335000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1355000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.34
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1334700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.61
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.76
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7794000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7794000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1193000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1193000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6601000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1265000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1950000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4651000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,230000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-149000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4502000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,935000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3567000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3567000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3566000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1383000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.58
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1412000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.53
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1382200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.58
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:35:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32351000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,488000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32839000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4317000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4317000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28522000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3466000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3583000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7049000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21473000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,765000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,214000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-551000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20922000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3581000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17341000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1383000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.04
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1412000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.68
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1382200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.04
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.72
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26107000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26107000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4371000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21736000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3878000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3734000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7612000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14124000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1118000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,523000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-595000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13529000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8885000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4644000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4644000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,16000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4628000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1319000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.51
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1307300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 17:38:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.08
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6077000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5949000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1256000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1256000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4693000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1252000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1150000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2402000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2291000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,297000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,132000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-165000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2126000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5962000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3836000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3836000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3865000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.96
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1319000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.93
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1307300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.96
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6512000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6512000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1032000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1032000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5480000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,879000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,789000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1668000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3812000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,291000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-141000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3671000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,959000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2712000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2712000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2718000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1306000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.08
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1319000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1306700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.08
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:14:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20030000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20158000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3115000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3115000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17043000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2626000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2584000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5210000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11833000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,821000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,391000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-430000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11403000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2923000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8480000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8480000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8493000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1306000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.5
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1319000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.44
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1306700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.5
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.56
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-92000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27478000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4190000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4190000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23288000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3618000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3792000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7410000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15878000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1086000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,531000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-555000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15323000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3744000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11579000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11579000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-22000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11601000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1306000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.86
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1319000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.78
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1306700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.86
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7141000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7141000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1126000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1126000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6015000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,897000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,864000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1761000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4254000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,269000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,130000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-139000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4115000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1046000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3069000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3069000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3073000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.35
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1317000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.33
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1307700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.35
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 16:16:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13518000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13646000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2083000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2083000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11563000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1747000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1795000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3542000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8021000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,241000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-289000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7732000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1964000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5768000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5768000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5775000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.42
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1317000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.38
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1307700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.42
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.04
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28463000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28466000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4287000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4287000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24179000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4144000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7714000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1037000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,500000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-537000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15928000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3736000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12192000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12192000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-21000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12213000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.3
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1317000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.21
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1307700000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.3
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.98
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6377000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6505000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5548000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,850000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,931000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1781000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3767000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-150000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3617000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,918000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2699000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2699000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2702000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.05
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1305300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.07
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 18:54:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28973000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29101000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4025000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4025000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25076000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3563000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4764000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8327000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16749000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,995000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,458000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-537000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16212000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3592000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12620000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12620000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12637000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.46
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1305300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.93
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22127000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22127000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4853000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4853000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17274000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4056000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5018000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9074000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8200000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1077000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,676000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-401000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7799000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2339000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5460000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5460000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5455000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1298000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.17
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1298800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 17:38:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.28
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5795000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5795000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4225000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1131000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1950000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3081000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1144000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,257000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1016000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1013000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1298000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1298800000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5596000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5596000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1086000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1086000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4510000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,948000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,939000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1887000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2623000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,264000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,305000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2664000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,565000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2099000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2099000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2097000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1296000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.6
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1294400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:16:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16332000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16332000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3283000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3283000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13049000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2925000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3068000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5993000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7056000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,820000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,547000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-273000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6783000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1326000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5457000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5457000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5452000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1296000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.16
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1294400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.2
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.71
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22409000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22281000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4539000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4539000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17742000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4177000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4218000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8395000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9347000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1117000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,679000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-438000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8909000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7288000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1621000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1621000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,34000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1587000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1296000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.24
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1294400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.24
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.23
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5648000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5648000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1196000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1196000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4452000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,980000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1192000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2172000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2280000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,266000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-194000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2086000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1819000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1819000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1817000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1298000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.39
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1297900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:26:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10736000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10736000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2197000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2197000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8539000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1977000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2129000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4433000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,556000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,242000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-314000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4119000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,761000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3358000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3358000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3355000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1298000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.58
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.56
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1297900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.58
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23325000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23197000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4485000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4485000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18712000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4108000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4068000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8176000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10536000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1144000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,524000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-620000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9916000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7682000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2234000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2234000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,26000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2208000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1298000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.7
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1297900000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.7
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5088000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5088000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1001000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1001000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4087000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,997000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,937000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1934000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2153000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,290000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,170000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-120000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2033000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,494000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1539000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1539000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1538000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1303400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 19:16:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24818000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-128000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24690000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4415000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4415000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20275000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4025000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3740000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7765000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12510000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1147000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,582000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-565000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11945000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8461000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3484000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3484000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3464000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1307000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1303400000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.13
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5879000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5879000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1683000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1683000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4196000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1204000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1899000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3103000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1093000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,243000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1051000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,808000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1901000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-788000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2689000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2689000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2696000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.13
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1277000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.13
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1270300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.13
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22449000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22449000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4675000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4675000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17774000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4381000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13487000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4287000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,995000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1868000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,873000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5160000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-204000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5364000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5364000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-22000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5386000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.24
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1277000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1270300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.24
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 17:38:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.52
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16570000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2992000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2992000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13578000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3177000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7207000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10384000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3194000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,752000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,817000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,65000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3259000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,584000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2675000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2675000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2690000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.09
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1266300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.89
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22365000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22365000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4562000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4562000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17803000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4308000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9157000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4338000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1009000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,946000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4275000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1597000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2678000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2678000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2693000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.1
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1266300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.11
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.46
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5604000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5604000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1035000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1035000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4569000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1052000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4990000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6042000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1473000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,250000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,222000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1501000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-333000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1168000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1168000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1165000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1267000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1266300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:16:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10966000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10966000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9009000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2125000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2217000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4342000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4667000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,502000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,595000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,93000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4760000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,917000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3843000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3843000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3855000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1277000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1270300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.03
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.26
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22357000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22357000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4613000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4613000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17744000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4204000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5106000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9310000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8434000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1023000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1029000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8440000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2495000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5945000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5945000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5955000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1277000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.62
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1270300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.65
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.4
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1000000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1000000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4685000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1095000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1160000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2255000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2430000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,248000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,228000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2410000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,535000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1875000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1875000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1880000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1277000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1270300000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:26:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5281000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5281000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,957000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4324000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1030000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1057000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2087000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2237000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,254000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,367000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,113000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2350000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,382000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1968000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1968000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1975000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1276000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.55
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1283000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1274200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.55
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 19:03:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22320000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4809000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4809000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17511000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4089000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5138000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9227000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8284000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1041000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,873000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-168000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8116000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2227000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5889000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5889000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5892000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1276000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1283000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.54
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1274200000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.34
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22716000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22716000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4687000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4687000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18029000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4427000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9150000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13577000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4452000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,982000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1343000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,361000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4813000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-121000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4934000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4934000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4962000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1262000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.9
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1261000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.92
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.57
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5548000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5548000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,969000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,969000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4579000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1076000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1101000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2177000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2402000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,241000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-158000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-399000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2003000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,465000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1538000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1538000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1551000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1262000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.23
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1270000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.22
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1261000000.0
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.23
Gilead Sciences Inc,GILD,549300WTZWR07K8MNV44,0000882095,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 19:03:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.68
